Home > Qtrly Results > NATCO PHARMA

NATCO PHARMA
Quarterly Results Analysis [Dec2023]

NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹759 Cr ₹1,031 Cr ₹1,141 Cr ₹898 Cr ₹493 Cr ₹432 Cr ₹885 Cr ₹597 Cr
Expenses ₹491 Cr ₹573 Cr ₹613 Cr ₹559 Cr ₹387 Cr ₹337 Cr ₹489 Cr ₹615 Cr
Operating Income ₹268 Cr ₹458 Cr ₹528 Cr ₹339 Cr ₹106 Cr ₹95 Cr ₹395 Cr ₹-19 Cr
Other Income ₹37 Cr ₹29 Cr ₹20 Cr ₹29 Cr ₹21 Cr ₹21 Cr ₹34 Cr ₹14 Cr
Interest ₹5 Cr ₹4 Cr ₹4 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹7 Cr
Depreciation ₹44 Cr ₹44 Cr ₹44 Cr ₹41 Cr ₹42 Cr ₹42 Cr ₹40 Cr ₹38 Cr
Profit Before Tax ₹256 Cr ₹440 Cr ₹500 Cr ₹324 Cr ₹81 Cr ₹70 Cr ₹386 Cr ₹-50 Cr
Profit After Tax ₹213 Cr ₹369 Cr ₹420 Cr ₹276 Cr ₹62 Cr ₹57 Cr ₹320 Cr ₹-51 Cr
EPS ₹11.88 ₹20.61 ₹23.48 ₹15.11 ₹3.41 ₹3.11 ₹17.56 ₹-2.77
Industry Peers & Returns1W1M1Y
NATCO PHARMA 0.8% -6.7% 74%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

NATCO PHARMA Quarterly Revenues

Revenues
Q-o-Q

-26.45 %

Y-o-Y

54.03 %

Quarters Revenues % Change
Dec2023 ₹759 Cr
-26.45
Sep2023 ₹1,031 Cr
-9.57
Jun2023 ₹1,141 Cr
27.02
Mar2023 ₹898 Cr
82.31
Dec2022 ₹493 Cr
13.98
Sep2022 ₹432 Cr
-51.15
Jun2022 ₹885 Cr
48.22
Mar2022 ₹597 Cr -

NATCO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-41.46 %

Y-o-Y

153.16 %

Quarters Operating Profit % Change
Dec2023 ₹268 Cr
-41.46
Sep2023 ₹458 Cr
-13.26
Jun2023 ₹528 Cr
55.71
Mar2023 ₹339 Cr
220.21
Dec2022 ₹106 Cr
11.12
Sep2022 ₹95 Cr
-75.89
Jun2022 ₹395 Cr
Positive
Mar2022 ₹-19 Cr -
Operating Margins
Q-o-Q

-20.42 %

Y-o-Y

64.37 %

Quarters Operating Margin% % Change
Dec2023 35.34%
-20.42
Sep2023 44.41%
-4.08
Jun2023 46.3%
22.58
Mar2023 37.77%
75.67
Dec2022 21.5%
-2.54
Sep2022 22.06%
-50.64
Jun2022 44.69%
Positive
Mar2022 -3.12% -

NATCO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-42.36 %

Y-o-Y

241.41 %

Quarters Profit After Tax % Change
Dec2023 ₹213 Cr
-42.36
Sep2023 ₹369 Cr
-12.21
Jun2023 ₹420 Cr
52.39
Mar2023 ₹276 Cr
342.70
Dec2022 ₹62 Cr
9.68
Sep2022 ₹57 Cr
-82.27
Jun2022 ₹320 Cr
Positive
Mar2022 ₹-51 Cr -
PAT Margins
Q-o-Q

-21.63 %

Y-o-Y

121.66 %

Quarters PAT Margin(%) % Change
Dec2023 28.04 %
-21.63
Sep2023 35.78 %
-2.90
Jun2023 36.85 %
19.95
Mar2023 30.72 %
142.85
Dec2022 12.65 %
-3.80
Sep2022 13.15 %
-63.69
Jun2022 36.22 %
Positive
Mar2022 -8.46 % -

NATCO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-42.36 %

Y-o-Y

248.39 %

Quarters EPS % Change
Dec2023 ₹11.88
-42.36
Sep2023 ₹20.61
-12.22
Jun2023 ₹23.48
55.39
Mar2023 ₹15.11
343.11
Dec2022 ₹3.41
9.65
Sep2022 ₹3.11
-82.29
Jun2022 ₹17.56
Positive
Mar2022 ₹-2.77 -

You may also like the below Video Courses